Company Product Description Indication Status
Abbvie Inc., of North Chicago Botox (onabotulinumtoxinA) Botulinum toxin type A Spasticity FDA approved supplemental BLA for use in pediatric patients, 2 and older, including those with lower limb spasticity caused by cerebral palsy
Ipsen SA, of Paris Dysport (abobotulinumtoxinA) Botulinum toxin type A Spasticity FDA approved expanded use in pediatric patients

Notes

For more information about individual companies and/or products, see Cortellis.

No Comments